Indirect lymphography with iotrolan.
Identifieur interne : 005783 ( PubMed/Checkpoint ); précédent : 005782; suivant : 005784Indirect lymphography with iotrolan.
Auteurs : H. Partsch ; C. Stöberl ; M. Wruhs ; B I Wenzel-HoraSource :
- Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband [ 0178-4609 ] ; 1989.
Descripteurs français
- KwdFr :
- MESH :
- administration et posologie : Acides triiodo-benzoïques, Produits de contraste.
- imagerie diagnostique : Lymphoedème.
- Essais cliniques comme sujet, Humains, Iodo-benzoates, Lymphographie, Méthode en double aveugle, Relation dose-effet des médicaments.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Contrast Media, Triiodobenzoic Acids.
- diagnostic imaging : Lymphedema.
- Clinical Trials as Topic, Dose-Response Relationship, Drug, Double-Blind Method, Humans, Iodobenzoates, Lymphography.
Abstract
Iotrolan was used in concentrations of 240 and 300 mg I/ml for indirect lymphography in a total of 70 patients, and permitted a diagnostic evaluation of the peripheral lymphatics in all cases. The contrast quality was found to correlate with the concentration used. The concentration of 300 mg I/ml Iotrolan was judged to provide the better contrast density and definition. Side effects were limited to transient local erythema and pain during the infusion in one patient and a protracted reaction resembling serum sickness in another patient (Iotrolan 240 mg I/ml). Because of its excellent tolerance, Iotrolan is particularly suitable after subepidermal infusion for indirect lymphography, during which the local lymph drainage of cutaneous regions of interest can be evaluated.
PubMed: 2568790
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:2568790Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Indirect lymphography with iotrolan.</title><author><name sortKey="Partsch, H" sort="Partsch, H" uniqKey="Partsch H" first="H" last="Partsch">H. Partsch</name></author><author><name sortKey="Stoberl, C" sort="Stoberl, C" uniqKey="Stoberl C" first="C" last="Stöberl">C. Stöberl</name></author><author><name sortKey="Wruhs, M" sort="Wruhs, M" uniqKey="Wruhs M" first="M" last="Wruhs">M. Wruhs</name></author><author><name sortKey="Wenzel Hora, B I" sort="Wenzel Hora, B I" uniqKey="Wenzel Hora B" first="B I" last="Wenzel-Hora">B I Wenzel-Hora</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1989">1989</date><idno type="RBID">pubmed:2568790</idno><idno type="pmid">2568790</idno><idno type="wicri:Area/PubMed/Corpus">006083</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">006083</idno><idno type="wicri:Area/PubMed/Curation">006083</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">006083</idno><idno type="wicri:Area/PubMed/Checkpoint">006083</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">006083</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Indirect lymphography with iotrolan.</title><author><name sortKey="Partsch, H" sort="Partsch, H" uniqKey="Partsch H" first="H" last="Partsch">H. Partsch</name></author><author><name sortKey="Stoberl, C" sort="Stoberl, C" uniqKey="Stoberl C" first="C" last="Stöberl">C. Stöberl</name></author><author><name sortKey="Wruhs, M" sort="Wruhs, M" uniqKey="Wruhs M" first="M" last="Wruhs">M. Wruhs</name></author><author><name sortKey="Wenzel Hora, B I" sort="Wenzel Hora, B I" uniqKey="Wenzel Hora B" first="B I" last="Wenzel-Hora">B I Wenzel-Hora</name></author></analytic><series><title level="j">Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband</title><idno type="ISSN">0178-4609</idno><imprint><date when="1989" type="published">1989</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Clinical Trials as Topic</term><term>Contrast Media (administration & dosage)</term><term>Dose-Response Relationship, Drug</term><term>Double-Blind Method</term><term>Humans</term><term>Iodobenzoates</term><term>Lymphedema (diagnostic imaging)</term><term>Lymphography</term><term>Triiodobenzoic Acids (administration & dosage)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acides triiodo-benzoïques (administration et posologie)</term><term>Essais cliniques comme sujet</term><term>Humains</term><term>Iodo-benzoates</term><term>Lymphoedème (imagerie diagnostique)</term><term>Lymphographie</term><term>Méthode en double aveugle</term><term>Produits de contraste (administration et posologie)</term><term>Relation dose-effet des médicaments</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Contrast Media</term><term>Triiodobenzoic Acids</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Acides triiodo-benzoïques</term><term>Produits de contraste</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Clinical Trials as Topic</term><term>Dose-Response Relationship, Drug</term><term>Double-Blind Method</term><term>Humans</term><term>Iodobenzoates</term><term>Lymphography</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Essais cliniques comme sujet</term><term>Humains</term><term>Iodo-benzoates</term><term>Lymphographie</term><term>Méthode en double aveugle</term><term>Relation dose-effet des médicaments</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Iotrolan was used in concentrations of 240 and 300 mg I/ml for indirect lymphography in a total of 70 patients, and permitted a diagnostic evaluation of the peripheral lymphatics in all cases. The contrast quality was found to correlate with the concentration used. The concentration of 300 mg I/ml Iotrolan was judged to provide the better contrast density and definition. Side effects were limited to transient local erythema and pain during the infusion in one patient and a protracted reaction resembling serum sickness in another patient (Iotrolan 240 mg I/ml). Because of its excellent tolerance, Iotrolan is particularly suitable after subepidermal infusion for indirect lymphography, during which the local lymph drainage of cutaneous regions of interest can be evaluated.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">2568790</PMID><DateCreated><Year>1989</Year><Month>08</Month><Day>17</Day></DateCreated><DateCompleted><Year>1989</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0178-4609</ISSN><JournalIssue CitedMedium="Print"><Volume>128</Volume><PubDate><Year>1989</Year></PubDate></JournalIssue><Title>Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband</Title><ISOAbbreviation>Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd</ISOAbbreviation></Journal><ArticleTitle>Indirect lymphography with iotrolan.</ArticleTitle><Pagination><MedlinePgn>178-81</MedlinePgn></Pagination><Abstract><AbstractText>Iotrolan was used in concentrations of 240 and 300 mg I/ml for indirect lymphography in a total of 70 patients, and permitted a diagnostic evaluation of the peripheral lymphatics in all cases. The contrast quality was found to correlate with the concentration used. The concentration of 300 mg I/ml Iotrolan was judged to provide the better contrast density and definition. Side effects were limited to transient local erythema and pain during the infusion in one patient and a protracted reaction resembling serum sickness in another patient (Iotrolan 240 mg I/ml). Because of its excellent tolerance, Iotrolan is particularly suitable after subepidermal infusion for indirect lymphography, during which the local lymph drainage of cutaneous regions of interest can be evaluated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Partsch</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Stöberl</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Wruhs</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wenzel-Hora</LastName><ForeName>B I</ForeName><Initials>BI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd</MedlineTA><NlmUniqueID>0372776</NlmUniqueID><ISSNLinking>0178-4609</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007463">Iodobenzoates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014283">Triiodobenzoic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>16FL47B687</RegistryNumber><NameOfSubstance UI="C033300">iotrolan</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="N">Contrast Media</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007463" MajorTopicYN="Y">Iodobenzoates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008220" MajorTopicYN="Y">Lymphography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014283" MajorTopicYN="Y">Triiodobenzoic Acids</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1989</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1989</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1989</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">2568790</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Partsch, H" sort="Partsch, H" uniqKey="Partsch H" first="H" last="Partsch">H. Partsch</name><name sortKey="Stoberl, C" sort="Stoberl, C" uniqKey="Stoberl C" first="C" last="Stöberl">C. Stöberl</name><name sortKey="Wenzel Hora, B I" sort="Wenzel Hora, B I" uniqKey="Wenzel Hora B" first="B I" last="Wenzel-Hora">B I Wenzel-Hora</name><name sortKey="Wruhs, M" sort="Wruhs, M" uniqKey="Wruhs M" first="M" last="Wruhs">M. Wruhs</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005783 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 005783 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:2568790
|texte= Indirect lymphography with iotrolan.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:2568790" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |